Janux Therapeutics JANX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$24.36M-3.6% | -$31.95M-58.0% | -$24.31M+13.4% | -$33.86M-468% | -$23.51M-59.3% | ||
| $469K-9.6% | $468K-8.6% | $501K-1.8% | $541K+6.9% | $519K-2.4% | ||
| $9.27M-13.4% | $9.52M+52.2% | $9.04M-41.2% | $10.96M+90.4% | $10.7M+90.3% | ||
| -$12.34M+27.5% | -$28.54M-70.7% | -$12.86M-476% | -$23.81M-138% | -$17.02M-14.7% | ||
| $273K-26.4% | $106K+152% | $93K+272% | $473K+398% | $371K+88.3% | ||
| $8.29M+102% | —— | —— | —— | -$340.39M-199% | ||
| $3.55M+540% | $2.94M-99.2% | $493K-70.1% | $954K-65.5% | $554K-99.8% | ||
| -$506K+99.9% | $0-100% | -$4.06M-134% | -$21.3M+89.3% | -$356.86M-284% | ||
| -$12.61M+27.5% | -$28.65M-70.9% | -$12.95M-474% | -$24.29M-140% | -$17.4M-15.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Janux Therapeutics generate?
- Janux Therapeutics (JANX) generated -$77.5M in operating cash flow over the trailing twelve months.
- What is Janux Therapeutics's free cash flow?
- After $945.0K of capital expenditures, Janux Therapeutics's free cash flow was -$78.5M over the trailing twelve months, down 68.7% year over year.
- Where does Janux Therapeutics's cash flow data come from?
- Every line is extracted from Janux Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
